September 16, 2026 07:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Gurugram biker hit by car: Two including main accused arrested after viral road rage video, attempt to murder case filed | Gurugram horror caught on camera: ‘I felt unsafe’—car chases, rams woman biker and flees | BRICS veg menu row: ‘Why shouldn’t we showcase it?’—Harsh Goenka hits back after Rahul Gandhi’s ‘80%’ remark | India-UAE Comprehensive Strategic Partnership in focus: Modi meets Abu Dhabi Crown Prince on BRICS sidelines | Xi Jinping lands in India for BRICS; big Modi meeting set for New Delhi | ‘Hospitality on another level’: South African official stunned by India’s BRICS hosting | Suvendu Adhikari eats fish bhog at Kalighat Temple amid Bageshwar Baba row | Bangladeshi Hindu monk Chinmoy Krishna Das breaks down emotionally as he gets 5-hour parole to attend mother’s funeral | Sheikh Hasina’s daughter Saima Wazed quits WHO post amid fraud allegations | After days of silence, China confirms Xi Jinping’s India visit for BRICS Summit

FIR against Snapdeal CEO for selling prescription drugs online

| | May 01, 2015, at 11:58 pm
Mumbai, May 1 (IBNS) Maharashtra's Food and Drugs Administration (FDA) has ordered that a First Information Report (FIR) be filed against Kunal Bahl, the CEO of e-commerce giant Snapdeal.com, for the sale of prescription drugs online.
FDA commissioner Harshadeep Kamble said on Friday said the FIR has been ordered against  Bahl and directors of the company.
 
The FDA said it had received information about the alleged sale of a cough syrup, and certain tablets, both prescription drugs that can be sold only when prescribed by medical practitioner.
 
The FDA had issued a notice to the company asking it to delist the drugs and also furnish details of the drugs it offered for sale on the portal Snapdeal.com.
 
In a statement on Friday, Snapdeal said they are assisting in the probe and have delisted the products.
 
"In this matter, we are assisting the FDA team in this investigation and we will continue to do so. We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," the statement said.
 
The FDA has said it is also checking to see if other e-retailers have sold drugs online.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.